Metavia Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.19

-0.01 (-0.83%)

As of May 16, 2:33 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +568.1% upside

Low Target $5.82

Average Target $7.95

High Target $9.13

Current Price $1.19

Current
$1.19

Target
$7.95

$5.82 $7.95 avg $9.13

Scenario Analysis

Bear Case

$5.82

389.1%

Low target

Base Case

$7.95

+568.1%

Avg target

Bull Case

$9.13

+667.2%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$19.03

-93.7% from high

52-Week Low

$0.97

+23.2% from low

Target vs 52W High

$7.95

-58.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%